HEPACAM: A Protein Involved in Cell-Cell Adhesion and Potential Drug Target

Target Name: HEPACAM

NCBI ID: G220296

HEPACAM

HEPACAM: A Protein Involved in Cell-Cell Adhesion and Potential Drug Target

HEPACAM is a protein that is expressed in the liver and glial cells, which are the cells that support and protect the brain. It is a member of the cadherin family, which is a group of transmembrane proteins that are involved in cell-cell adhesion.

The study of HEPACAM and its potential as a drug target or biomarker has gained significant interest in recent years. HEPACAM has been shown to play a role in the development and progression of various neurological diseases, including neurodegenerative diseases, cancer, and autoimmune disorders.

One of the key functions of HEPACAM is its role in cell-cell adhesion. cadherins are involved in the formation of tight junctions, which are a type of cell-cell adhesion that helps to maintain the integrity of tissues and organs. In the brain, tight junctions are critical for the development and maintenance of neural circuits and are involved in the regulation of a wide range of physiological processes, including sensory perception, motor function, and memory.

HEPACAM is involved in the formation of tight junctions by helping to regulate the activity of cadherin-associated proteins, such as cadherin, transmembrane protein 1 (TMP1), and sialyl-protein GQ (SPGQ). These proteins, in turn, help to regulate the level of adhesion between cells and contribute to the development of tight junctions.

In addition to its role in cell-cell adhesion, HEPACAM has also been shown to play a role in the regulation of inflammation and immune responses. It is involved in the recruitment of immune cells to sites of infection or damage, and is also involved in the regulation of the production of pro-inflammatory cytokines.

The study of HEPACAM and its potential as a drug target or biomarker has led to a number of important findings. For example, studies have shown that inhibiting the activity of HEPACAM can help to reduce the production of pro-inflammatory cytokines and improve the regulation of immune cell responses. This suggests that HEPACAM may be a useful target for the treatment of autoimmune disorders and other inflammatory conditions.

In addition, studies have also shown that HEPACAM is involved in the regulation of cell survival and metabolism. For example, HEPACAM has been shown to play a role in the regulation of the production of mitochondrial proteins, which are important for energy metabolism. This suggests that HEPACAM may be a useful target for the treatment of neurodegenerative diseases.

Overall, the study of HEPACAM has led to a better understanding of its role in cell-cell adhesion and its potential as a drug target or biomarker. Further research is needed to fully understand the functions of HEPACAM and its potential as a therapeutic agent.

Protein Name: Hepatic And Glial Cell Adhesion Molecule

Functions: Involved in regulating cell motility and cell-matrix interactions. May inhibit cell growth through suppression of cell proliferation

The "HEPACAM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HEPACAM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets